News | March 06, 2023
Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The audit was commenced for newly renovated manufacturing Block 1, Block 2, and Block 3
Rocuronium Bromide Injection is a neuromuscular blocking agent
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
Julian Collins, Jana Windt and Michiel Stork join biopharma company’s leadership team
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
Jan Aushadhi Diwas celebrations to generate awareness about the usages of generic medicines and benefits of Jan Aushadhi Pariyojana
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health.
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Subscribe To Our Newsletter & Stay Updated
